|
|
|
|
|
|
By Zachary Golden, Manager & Deloitte NextGen Therapies Value Chain Innovation Leader, Deloitte Consulting LLP | Optimizing slot management is essential for cell and gene therapy manufacturers to overcome high costs, long turnaround times, and limited patient access by enabling real-time scheduling, better resource utilization, and advanced technology integration. | |
|
|
| MAPK Signaling Pathway | Article | Danaher Life Sciences | Mitogen-activated protein kinase cascades regulate key cellular processes like proliferation, differentiation, and apoptosis. Explore how these pathways maintain cellular homeostasis and contribute to disease development. |
|
|
|
| Use Of Roche Recombinant Trypsin For Cell Culture Applications | Application Note | By Dr. Andrea Normann, Dr. Manuela Poignee-Heger, and Dr. Peter Hloch, Roche CustomBiotech | Review the use of a recombinant trypsin in cell culture applications, such as the detachment of adherent cells, in particular with cell lines used in vaccine production. |
|
|
|
|
| Closed System And Custom Solutions For Bioproduction | Webinar | Corning Life Sciences | Learn how closed system solutions offer process flexibility, reduce contamination risks, and can contribute to time saving or simplifying steps in manufacturing. Review customized solutions and key considerations. |
|
|
|
|
|
|
|
|
| Webinar: From Flow Data to GMP Decisions: How Express Modes Standardize QC | Unlock faster, more reliable QC with Miltenyi Biotec’s Express Modes. This live webinar shows how labs standardize flow cytometry across shifts, sites, and operators—eliminating manual gating, reducing variability, and accelerating batch release. Attendees gain insider tips directly from Miltenyi scientists on implementing Express Modes into MACSQuant® Analyzer workflows to boost compliance, efficiency, and confidence in GMP decisions. Click here to learn more. |
|
|
|
|
|
|
|
|
|
| Advancing the Future of Cell & Gene Therapy | This 11-12 November, Cell 2025 unites 1,000+ leading experts across the CGT value chain to solve key challenges, from scalable bioprocessing and regulatory hurdles to accelerating development timelines. Gain practical strategies across cell culture, therapy development, and CGT manufacturing, and hear from world-renowned leaders Bobby Gaspar (CEO, Orchard Therapeutics), Christof Von Kalle, (Director & BIH Chair, Research Clinic Luxemburg), and Dame Molly Stevens (University of Oxford). Register Now |
|
|
| Connect With Cell & Gene: |
|
|
|